{"gene":"EBF1","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":1995,"finding":"EBF (EBF1) is required for B cell differentiation; targeted gene disruption in mice shows EBF-deficient mice lack B cells with rearranged immunoglobulin D and JH gene segments but contain B220+CD43+ progenitor cells, placing EBF function at a stage before Ig gene rearrangement but after B-lymphoid commitment.","method":"Targeted gene disruption (knockout mouse), flow cytometry, gene expression analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout with defined cellular phenotype, foundational study replicated by subsequent work","pmids":["7542362"],"is_preprint":false},{"year":1995,"finding":"EBF contains a novel zinc coordination motif (H-X3-C-X2-C-X5-C) in its DNA-binding domain critical for DNA recognition, a C-terminal helix-loop-helix-related dimerization domain, and a serine/threonine-rich transcriptional activation domain; the DNA-binding domain alone can mediate both dimerization on optimized half-sites and transcriptional activation.","method":"Mutational analysis, DNA-binding assays, transcriptional activation assays with heterologous domain fusions","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis with functional validation, replicated by structural work","pmids":["7796816"],"is_preprint":false},{"year":1997,"finding":"EBF and E47 synergize to induce expression of the endogenous immunoglobulin surrogate light chain genes lambda5 and VpreB in Ba/F3 hematopoietic cells; multiple functional EBF and E47 binding sites were identified in the lambda5 promoter/enhancer, establishing lambda5 as a direct genetic target.","method":"Stable transfection of cDNAs encoding EBF or E47 into Ba/F3 cells, endogenous gene expression analysis, binding site identification","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct activation of endogenous target genes demonstrated with binding site identification, replicated by later work","pmids":["9252117"],"is_preprint":false},{"year":1998,"finding":"E2A protein E12 induces EBF expression in a macrophage-like cell line, and EBF alone activates a subset of B lineage genes, placing E2A upstream of EBF in the transcriptional hierarchy of B cell lineage specification.","method":"Ectopic expression of E12 and EBF in 70Z/3-derived macrophage line, gene expression analysis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — epistasis established by ectopic expression in defined cellular context, replicated across multiple subsequent studies","pmids":["9705952"],"is_preprint":false},{"year":1999,"finding":"EBF directly binds and activates the Pax5 promoter; genetic collaboration between EBF and E2A is demonstrated by Ebf+/- E2a+/- compound heterozygous mice showing stronger defects in pro-B cell differentiation than single mutants, with reduced Pax5, Rag1, Rag2, and mb-1 expression.","method":"Compound heterozygous mouse genetics, promoter binding assays, gene expression analysis","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct promoter binding plus genetic epistasis, replicated by subsequent studies","pmids":["10435576"],"is_preprint":false},{"year":1999,"finding":"Ebf1 controls cell differentiation in the murine embryonic striatum; Ebf1 targeted disruption causes failure to downregulate SVZ-restricted genes and failure to activate mantle-specific genes in postmitotic cells, followed by increased cell death and dramatic reduction in postnatal striatum size.","method":"Targeted gene disruption (knockout mouse), in situ hybridization, histological analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout with defined molecular and cellular phenotype in neuronal context","pmids":["10556054"],"is_preprint":false},{"year":2000,"finding":"EBF promotes VlambdaIII-Jlambda1 recombination in non-lymphoid embryonic kidney cells when co-expressed with RAG1/RAG2, while E2A (but not EBF) activates IgK VK1J rearrangement; either E2A or EBF can activate IgH DH4J recombination, demonstrating distinct and partially overlapping roles in V(D)J recombination.","method":"Transfection of E2A, EBF, RAG1/RAG2 into embryonic kidney cells, PCR-based detection of recombination products","journal":"Molecular cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct functional assay in non-lymphoid cells, single lab","pmids":["10882075"],"is_preprint":false},{"year":2002,"finding":"The EBF gene promoter contains functional binding sites for E-proteins (E47 activates the promoter) and for EBF itself, establishing an autoregulatory loop; a tissue-restricted factor also binds an upstream regulatory region in B-lineage cells.","method":"Primer extension, reporter gene assays, EMSA, transfection assays","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct DNA binding and functional reporter assays, single lab","pmids":["12077253"],"is_preprint":false},{"year":2003,"finding":"Enforced expression of EBF in hematopoietic stem cells restricts lymphopoiesis almost exclusively to the B cell lineage at the expense of T cells, NK cells, and lymphoid dendritic cells, demonstrating an instructive role for EBF in B cell fate specification.","method":"Retroviral transduction of EBF into hematopoietic progenitors, bone marrow transplantation, flow cytometric analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — gain-of-function with clear lineage restriction phenotype, consistent with loss-of-function data","pmids":["12970188"],"is_preprint":false},{"year":2003,"finding":"STAT5 (phosphorylated downstream of IL-7 receptor) binds to the EBF-binding site in the Pax5 promoter (SBM) and enhances EBF-mediated transcription of Pax5, providing a direct mechanistic link between IL-7R signaling and Pax5 expression via EBF.","method":"Reporter gene assays, EMSA, chromatin immunoprecipitation","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assays in a pre-B cell line, single lab","pmids":["12811842"],"is_preprint":false},{"year":2005,"finding":"IL-7 receptor signaling upregulates EBF expression (via STAT5 activation) in pre-pro-B cells, and enforced EBF expression partially rescues B cell development in IL-7Ralpha-/- mice, placing IL-7R signaling upstream of EBF in the transcriptional hierarchy.","method":"IL-7 knockout and IL-7Ralpha knockout mouse analysis, retroviral EBF transduction, STAT5 activation experiments, in vivo rescue","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with in vivo rescue, multiple orthogonal approaches","pmids":["15837809"],"is_preprint":false},{"year":2005,"finding":"Notch signaling (Notch1-IC or Delta4 ligand-induced) inhibits EBF function by reducing EBF DNA-binding activity, thereby down-regulating EBF-regulated promoters; this provides a mechanism by which Notch promotes T cell fate over B cell fate by targeting both EBF and E2A.","method":"Transient transfection of Notch1-IC into pre-B cell line, reporter assays, DNA-binding assays, ligand stimulation of endogenous Notch receptors","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional reporter assays and DNA-binding assays, single lab","pmids":["15920012"],"is_preprint":false},{"year":2006,"finding":"Ebf1 promotes adipogenesis by directly activating the PPARgamma1 promoter and the C/EBPalpha promoter; Ebf1 itself is induced by C/EBPbeta and delta binding its promoter; knockdown of Ebf1 and Ebf2 by shRNA blocks 3T3-L1 differentiation, establishing a critical role for Ebf1 within the adipogenic transcriptional cascade.","method":"Overexpression in NIH 3T3 fibroblasts, shRNA knockdown in 3T3-L1 cells, promoter binding assays, reporter assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct promoter activation and loss-of-function with defined phenotype, multiple orthogonal methods","pmids":["17060461"],"is_preprint":false},{"year":2008,"finding":"EBF restricts alternative lineage options (myeloid, T lineage) and promotes B cell fate commitment independently of Pax5; ectopic EBF in multipotent progenitors directs B cell generation, antagonizes C/EBPalpha, PU.1 and Id2 expression, and sustained EBF expression in Pax5-/- pro-B cells is sufficient to repress myeloid and T lineage genes.","method":"Conditional deletion of EBF, ectopic expression in multipotential progenitors, in vivo lineage fate analysis, gene expression profiling","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — combined gain- and loss-of-function with clear lineage fate phenotypes","pmids":["18176567"],"is_preprint":false},{"year":2008,"finding":"EBF1 is required for B-lineage priming in common lymphoid progenitors (CLPs); EBF1-deficient CLPs show no B lineage gene transcription and lack IgH chain recombination; Pax5, Pou2af1 (OcaB), and FoxO1 promoters contain functional EBF1 binding sites, establishing them as direct EBF1 target genes.","method":"Bone marrow transplantation of EBF1-deficient fetal liver cells, gene expression analysis, promoter binding site validation","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-autonomous analysis with direct binding site validation, multiple targets","pmids":["18714008"],"is_preprint":false},{"year":2009,"finding":"EBF reprograms mb-1 (Ig-alpha) promoters by increasing chromatin accessibility and initiating DNA demethylation, facilitating subsequent promoter activation by Pax5. SWI/SNF ATPases (Brg1/Brm) are required for transcriptional activation by EBF, while Mi-2/NuRD complex (Mi-2beta) opposes EBF by maintaining hypermethylated chromatin; knockdown of Mi-2beta greatly enhances chromatin accessibility and mb-1 transcription in response to EBF.","method":"Inducible EBF:ER and Pax5:ER fusion systems, shRNA knockdown of Brg1/Brm and Mi-2beta, chromatin accessibility assays, DNA methylation analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods including chromatin remodeling assays and DNA methylation, rigorous controls","pmids":["19549820"],"is_preprint":false},{"year":2009,"finding":"Ebf1-mediated downregulation of both Id2 and Id3 is essential for B cell lineage specification; enforced Ebf1 expression in IL-7Ralpha-/- bone marrow potently downregulates Id2 and Id3 mRNA and restores B cell differentiation in vivo; overexpression of either Id2 or Id3 in wild-type bone marrow blocks B cell specification at the prepro-B cell stage.","method":"Retroviral transduction of Ebf1 in IL-7Ralpha-/- bone marrow, in vivo rescue, Id2/Id3 overexpression","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo rescue with clear molecular mechanism, loss- and gain-of-function","pmids":["19122139"],"is_preprint":false},{"year":2009,"finding":"Ebf1 plays a role in regulating both the osteoblast and adipocyte lineages in vivo; Ebf1-/- mice show increased osteoblast numbers, bone formation parameters, and serum osteocalcin, as well as dramatically increased adipocyte numbers in bone marrow; Ebf1-deficient mice display features of lipodystrophy.","method":"Ebf1 knockout mouse analysis, histomorphometry, serum markers, histology","journal":"Bone","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout with multiple defined phenotypic readouts across two cell lineages","pmids":["19130908"],"is_preprint":false},{"year":2010,"finding":"The crystal structure of Ebf1 dimer bound to its palindromic recognition site reveals a pseudoimmunoglobulin-like fold with structural similarity to Rel homology domains of NFAT and NF-κB; each Ebf1 monomer contacts both palindromic half-sites via two loop-based modules and a unique Zn coordination motif, generating an extended contact area.","method":"X-ray crystallography","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with high-resolution structural determination","pmids":["20876732"],"is_preprint":false},{"year":2010,"finding":"Crystal structures of EBF family protein domains reveal: (1) DNA-binding domain resembling Rel homology superfamily but containing a unique zinc knuckle; (2) an IPT/TIG domain; (3) an atypical helix-loop-helix domain with a novel dimerization motif.","method":"X-ray crystallography of structured domains","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple crystal structures, structural determination of functional domains","pmids":["20592035"],"is_preprint":false},{"year":2010,"finding":"E2A and EBF1 bind regulatory elements in the Foxo1 locus; E2A and EBF1, as well as E2A and Foxo1, are wired together by cis-regulatory sequences; E47 occupancy directly results in H3K4 monomethylation across enhancer regions, establishing a positive regulatory network among E2A, EBF1, and Foxo1 in pro-B cells.","method":"ChIP-seq, genome-wide analysis of regulatory elements, histone modification analysis","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide ChIP-seq with multiple orthogonal methods","pmids":["20543837"],"is_preprint":false},{"year":2010,"finding":"EBF1 identifies the TET2 interaction partner; ChIP and western blotting show EBF1 interacts with TET2, suggesting a sequence-specific mechanism for TET2-mediated DNA demethylation.","method":"Chromatin immunoprecipitation, western blotting, sequence motif analysis","journal":"Nature communications","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single ChIP/western blot, single lab, limited mechanistic follow-up","pmids":["23863747"],"is_preprint":false},{"year":2011,"finding":"EBF1 is required for proliferation and survival of pro-B cells, and for signaling and function of peripheral B-cell subsets including B1 cells and marginal zone B cells; EBF1 targets c-Myb and Bcl-xL rescue survival defects; in mature B cells, EBF1 deficiency impairs BAFF-R and BCR-dependent Akt signaling; EBF1 is required for germinal center formation and class switch recombination.","method":"Conditional Ebf1 inactivation, v-Abl transformation, forced expression of EBF1 targets, genome-wide ChIP-seq and RNA analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout with multiple defined phenotypic readouts and genome-wide analysis","pmids":["22431510"],"is_preprint":false},{"year":2011,"finding":"EBF1 and FOXO1 act in a positive intergenic feedback circuitry; depletion of EBF1 severely reduces FOXO1 mRNA abundance in LY6D+ CLPs, and depletion of FOXO1 ablates EBF1 transcript levels; their transcriptional signatures in deficient cells are strikingly similar, indicating a common set of target genes.","method":"EBF1 and FOXO1 knockout mouse analysis, genome-wide transcription factor occupancy (ChIP-seq), transcriptome analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal genetic depletion with genome-wide occupancy data","pmids":["23213261"],"is_preprint":false},{"year":2011,"finding":"Ebf1 represses Rag transcription in pro-B cells downstream of Stat5/IL-7R signaling; Ebf1 directly regulates c-Myb, which also represses Rag; Ebf1 and c-Myb antagonize Foxo1 binding to the Rag locus; Ebf1 directly represses Foxo1 expression and directly activates Gfi1b expression.","method":"shRNA knockdown, chromatin immunoprecipitation, gene expression analysis in Abelson-transformed B cells","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and shRNA knockdown, single lab, cell line model","pmids":["24068669"],"is_preprint":false},{"year":2012,"finding":"Conditional deletion of Ebf1 in committed pro-B cells causes their conversion into innate lymphoid cells and T cells; EBF1 directly binds and represses Id2 and TCF-1 genes; both EBF1 and Pax5 are required for B lineage commitment by repressing distinct and common determinants of alternative cell fates.","method":"Conditional Ebf1 deletion in committed pro-B cells, lineage tracing, ChIP, gene expression analysis","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional deletion with defined molecular targets (ChIP) and lineage conversion phenotype","pmids":["23812095"],"is_preprint":false},{"year":2012,"finding":"Runx1-Cbfβ complexes bind the Ebf1 proximal promoter and are required for its epigenetic activation (Runx1-binding motifs are essential for reporter expression; Runx1-deficient pro-B cells have excessive H3K27 trimethylation at the Ebf1 proximal promoter); retroviral Ebf1 (but not Pax5) transduction into Runx1-deficient progenitors restores B cell development, establishing Runx1-Cbfβ as an upstream activator of Ebf1.","method":"Conditional Runx1/Runx3/Cbfβ deletion, ChIP, reporter assay, retroviral rescue","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct promoter binding with mutagenesis, epigenetic analysis, and in vivo rescue","pmids":["22665574"],"is_preprint":false},{"year":2012,"finding":"EBF1 is essential for B cell commitment, pro-B to pre-B cell transition, and for generation of marginal zone, B-1, follicular and germinal center B cells; BCR activation results in impaired intracellular signaling in EBF1-deficient follicular B cells; ectopic EBF1 expression efficiently induces B-1 cell development at the expense of conventional B cells.","method":"Conditional mutagenesis, BCR signaling assays, ChIP-seq, RNA-seq","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout with genome-wide analysis and gain-of-function","pmids":["22473956"],"is_preprint":false},{"year":2013,"finding":"EBF1 in mature adipocytes directly regulates components of PI3K/AKT, MAPK, and STAT1 signaling pathways; EBF1 knockdown significantly reduces insulin-stimulated glucose uptake and lipogenesis; genome-wide EBF1 occupies ~35,000 sites in adipocytes, mostly at enhancers, with cell-type-specific patterns distinct from B cells.","method":"EBF1 knockdown, transcriptional profiling, ChIP-seq, glucose uptake and lipogenesis assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide ChIP-seq combined with functional metabolic assays","pmids":["24174531"],"is_preprint":false},{"year":2013,"finding":"Zfp521 physically interacts with EBF1 and represses its transcriptional activity; deletion of Zfp521 leads to increased Ebf1 activity in osteoblasts and osteoclasts; the bone phenotype of Zfp521+/- mice is rescued in Zfp521+/-:Ebf1+/- mice, establishing a Zfp521-EBF1 rheostat for bone homeostasis.","method":"Co-immunoprecipitation, conditional deletion, genetic rescue (double heterozygotes), transcriptional assays","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — physical interaction plus genetic epistasis with in vivo rescue","pmids":["23569325"],"is_preprint":false},{"year":2015,"finding":"EBF1 heterozygosity results in increased DNA damage in pro-B cells and reduced expression of DNA repair genes including Rad51; ChIP data indicate Rad51 is a direct EBF1 target; combined heterozygous mutations in Ebf1 and Pax5 dramatically increase pro-B cell leukemia frequency in mice.","method":"Gene expression analysis, ChIP, DNA damage assays (UV), mouse leukemia model","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP for direct target identification, functional DNA repair assays, single lab","pmids":["25838350"],"is_preprint":false},{"year":2016,"finding":"The EBF1 C-terminal domain (CTD) is required for a specific set of B-lineage genes and promotes de novo chromatin accessibility and DNA demethylation in previously naive chromatin (pioneer function); the CTD enables EBF1 to bind inaccessible genomic regions with limited co-occupancy by other transcription factors, whereas it is dispensable for binding at regions occupied by multiple transcription factors.","method":"Genome-wide DNaseI hypersensitivity, DNA methylation analysis, ChIP-seq, comparison of EBF1wt and EBF1ΔC-expressing Ebf1-/- progenitor cells","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide chromatin accessibility and methylation with domain-specific mutant, multiple orthogonal methods","pmids":["26982363"],"is_preprint":false},{"year":2016,"finding":"CCR4-NOT complex interacts with EBF1; CNOT3 directly interacts with EBF1 at histidine 240 (H240A mutation disrupts this); the EBF1–CCR4-NOT interaction regulates gene-specific transcription and mRNA stability; mice with conditional Cnot3 inactivation phenocopy the block in early B cell differentiation, associated with impaired EBF1 autoregulation and reduced pre-BCR component expression.","method":"SILAC-based mass spectrometry of EBF1-associated proteins, mutagenesis (H240A), complementation of Ebf1-/- progenitors, conditional Cnot3 knockout, gene expression analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 / Strong — mass spectrometry identification, mutagenesis, and conditional knockout with multiple orthogonal methods","pmids":["27807034"],"is_preprint":false},{"year":2016,"finding":"MEF2C and EBF1 co-regulate a subset of B cell-specific genes at shared binding sites; MEF2C interacts with HDAC7 to repress myeloid transcription programs; the p38 MAPK pathway activates MEF2C to drive B cell differentiation.","method":"Genome-wide MEF2C and EBF1 ChIP-seq, Mef2c knockout mouse, co-immunoprecipitation","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide ChIP-seq and Co-IP, single lab","pmids":["26900922"],"is_preprint":false},{"year":2017,"finding":"EBF1 binds EBNA2 via EBNA2's N-terminal domain; EBF1 promotes assembly of EBNA2 chromatin complexes at CBF1-independent binding sites in B cells; EBNA2 exploits EBF1 to support metabolic processes and cell cycle progression (S-phase) in EBV-infected B cells, with the α1-helix of EBNA2's END domain promoting EBF1 binding.","method":"Co-immunoprecipitation, ChIP-seq, CBF1-deficient B cell analysis, EBV mutant analysis","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-immunoprecipitation, ChIP-seq, and EBV mutant functional analysis","pmids":["28968461"],"is_preprint":false},{"year":2018,"finding":"EBF1 functions as a pioneer transcription factor: in a time-resolved analysis, EBF1 occupancy precedes formation of chromatin accessibility; EBF1 also transiently occupies lineage-inappropriate genes prior to their silencing in pro-B cells; continuous EBF1 function is required for Cd79a promoter activity and maintenance of an accessible chromatin domain.","method":"Inducible EBF1 expression system in Ebf1-/- pre-pro-B cells, time-resolved ATAC-seq, ChIP-seq, gene expression analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — inducible system with time-resolved chromatin and transcription analysis, multiple orthogonal methods","pmids":["29440261"],"is_preprint":false},{"year":2019,"finding":"EBF1 regulates glomerular development through its actions in Foxd1+ stromal/mesangial progenitor cells; EBF1 deficiency in Foxd1-lineage cells impairs calcineurin/NFATc1 activation and decreases COX-2 expression; overexpressing COX-2 in EBF1-deficient mice partially restores glomerular development.","method":"Conditional Ebf1 deletion (Foxd1-cre, Podocin-cre), COX-2 overexpression rescue, signaling pathway analysis","journal":"Journal of the American Society of Nephrology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional knockout with partial molecular rescue, single lab","pmids":["31405952"],"is_preprint":false},{"year":2020,"finding":"EBF1's C-terminal domain (CTD) harbors a prion-like domain (PLD) capable of liquid-liquid phase separation, which is enhanced by interaction with the RNA-binding protein FUS; the CTD stabilizes EBF1 chromatin occupancy via recruitment of the chromatin remodeler Brg1; Brg1 partitions into phase-separated FUS condensates and co-localizes with EBF1 and FUS foci in pro-B cells; heterologous PLDs can confer pioneering function on EBF1ΔCTD.","method":"Phase separation assays, co-immunoprecipitation of FUS and Brg1, live-cell imaging, FRAP, heterologous domain rescue","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1 / Strong — biochemical reconstitution of phase separation, structural domain analysis, and functional rescue with multiple methods","pmids":["33159853"],"is_preprint":false},{"year":2020,"finding":"Conditional deletion of Ebf1 in bone marrow mesenchymal stromal cells (CAR cells/PαS cells) alters their cellular composition, chromatin structure, and gene expression (including reduced adhesion-related genes), impairs HSC adhesion leading to reduced HSC quiescence and diminished myeloid output, and causes persistent changes in HSC chromatin structure that persist through serial transplantations.","method":"Conditional Ebf1 deletion in MSCs, single-cell analysis, ATAC-seq, serial transplantation","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional deletion with single-cell and chromatin analysis, serial transplantation","pmids":["32066955"],"is_preprint":false},{"year":2021,"finding":"EBF1 directly activates Myc expression through six EBF1-responsive enhancer elements within the Myc locus, with one element of key importance identified by CRISPR-Cas9 targeting of EBF1-binding sites; PAX5, in contrast, represses Myc expression; ectopic MYC partially rescues B-cell expansion in EBF1-deficient cells, establishing Myc as a direct EBF1 target in pro-B-cell expansion.","method":"Chromosome conformation analysis, ATAC-seq, ChIP-seq, reporter assays, CRISPR-Cas9 mutagenesis, in vivo and in vitro rescue","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 / Strong — CRISPR-Cas9 mutagenesis of binding sites, multiple chromatin methods, and functional rescue","pmids":["33619557"],"is_preprint":false},{"year":2021,"finding":"EBF1 is expressed in pericytes and contributes to pericyte cell commitment; EBF1 silencing in human brain vascular pericytes reduces PDGFRβ, CD146, VEGF, angiopoietin-1, NG2, and TGF-β expression but not CD90, a mesenchymal marker.","method":"Immunohistochemistry, RT-qPCR, FACS, EBF1 siRNA knockdown in human pericytes","journal":"Histochemistry and cell biology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — knockdown with defined phenotype in primary cells, replicated across cell types","pmids":["34272603"],"is_preprint":false},{"year":2022,"finding":"EBF1 drives triple-negative breast cancer tumorigenicity by assembling a transcriptional complex with HIF1α that suppresses p300 activity, thereby fine-tuning HIF1α target gene expression and preventing excessive mitophagy-induced cell death; EBF1 depletion induces extensive cell mitophagy.","method":"EBF1 depletion, genome-wide ChIP-seq, co-immunoprecipitation, mitophagy assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq and Co-IP for complex identification, functional mitophagy assays, single lab","pmids":["35867755"],"is_preprint":false},{"year":2022,"finding":"Derepression and nuclear repositioning of EBF1 from the heterochromatic nuclear envelope to the euchromatic nuclear interior in T-ALL cells instructs widespread genome refolding (alterations in compartments, domain boundaries, enhancer positioning) and promotes targeted therapy resistance.","method":"Hi-C, ATAC-seq, ChIP-seq, imaging of nuclear repositioning, integrated multi-omics in therapy-sensitive and -resistant T-ALL","journal":"Molecular cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multi-omics integration with imaging, single lab, correlative repositioning mechanism","pmids":["35182476"],"is_preprint":false},{"year":2024,"finding":"Acute in vivo protein degradation reveals that Ebf1 functions predominantly as a transcriptional activator by inducing open chromatin at its target genes; Ebf1 represses Wapl (cohesin-release factor) to mediate prolonged loop extrusion across the Igh locus; Ebf1 directly activates surrogate light-chain genes Igll1 and Vpreb1 in pro-B cells; Ebf1 has largely unique target genes compared to E2A and Pax5 and is essential for early B cell maintenance.","method":"Acute protein degradation in mice (degron system), ATAC-seq, ChIP-seq, RNA-seq across pro-B, small pre-B, and immature B cells","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vivo acute protein degradation with genome-wide chromatin and transcriptome analysis, rigorous controls","pmids":["39179932"],"is_preprint":false}],"current_model":"EBF1 is a pioneer transcription factor with a pseudoimmunoglobulin-like/Rel-homology-fold DNA-binding domain and a prion-like C-terminal domain that mediates phase separation with FUS, enabling Brg1-dependent chromatin remodeling; it acts downstream of E2A and IL-7R/STAT5 signaling to activate a hierarchical network of B-lineage genes (including Pax5, Foxo1, surrogate light chains, Myc, and Igh locus accessibility via Wapl repression), represses alternative lineage programs (Id2, Id3, C/EBPalpha, PU.1, TCF-1) in concert with the CCR4-NOT complex, and functions at multiple subsequent stages of B cell development to control proliferation (via Myc), survival (via c-Myb/Bcl-xL), signaling (BAFF-R/BCR-Akt), and class switch recombination, while also regulating adipogenesis, osteoblast/adipocyte balance, neuronal differentiation, and pericyte commitment in non-hematopoietic lineages."},"narrative":{"mechanistic_narrative":"EBF1 is a lineage-instructive pioneer transcription factor that specifies and maintains the B lymphocyte program, acting at the earliest committed progenitor stages before immunoglobulin gene rearrangement [PMID:7542362, PMID:18714008]. It operates within a transcriptional hierarchy downstream of IL-7R/STAT5 signaling and the E2A protein E12, which induce EBF1 expression, and downstream of Runx1-Cbfβ, which epigenetically activates the Ebf1 promoter [PMID:9705952, PMID:15837809, PMID:22665574]; EBF1 in turn sustains its own expression through an autoregulatory loop and wires a positive feedback circuit with FOXO1 [PMID:12077253, PMID:23213261]. EBF1 recognizes palindromic DNA sites through a pseudoimmunoglobulin-like/Rel-homology-related DNA-binding domain bearing a unique zinc-coordination motif, dimerizes via an atypical helix-loop-helix domain, and activates transcription through a serine/threonine-rich activation domain [PMID:7796816, PMID:20876732, PMID:20592035]. Its pioneer activity resides in a C-terminal prion-like domain that drives liquid-liquid phase separation with FUS and recruits the SWI/SNF remodeler Brg1, enabling EBF1 to open and demethylate previously naive chromatin ahead of accessibility formation [PMID:19549820, PMID:26982363, PMID:29440261, PMID:33159853]. Through these mechanisms EBF1 directly activates the B-cell network—Pax5, Foxo1, the surrogate light-chain genes Igll1/Vpreb1, and Myc—and promotes Igh locus accessibility by repressing the cohesin-release factor Wapl, while repressing alternative-lineage determinants including Id2, Id3, and TCF-1, an activity it also coordinates with the CCR4-NOT complex through a direct CNOT3 interaction [PMID:9252117, PMID:10435576, PMID:18714008, PMID:23812095, PMID:27807034, PMID:33619557, PMID:39179932]. Loss of EBF1 in committed pro-B cells permits their conversion to T and innate lymphoid cells, and EBF1 additionally controls pro-B proliferation, survival, and BCR/BAFF-R signaling at later developmental stages [PMID:22431510, PMID:23812095, PMID:22473956]. Beyond the B lineage, EBF1 governs striatal neuronal differentiation, the osteoblast/adipocyte balance, adipogenesis and adipocyte insulin signaling, bone-marrow stromal support of hematopoietic stem cells, and pericyte commitment, demonstrating broadly redeployed differentiation-control function [PMID:10556054, PMID:17060461, PMID:19130908, PMID:24174531, PMID:32066955].","teleology":[{"year":1995,"claim":"Established that EBF1 is genetically required for B cell development at a defined stage, fixing its place in the B-lineage hierarchy before immunoglobulin rearrangement.","evidence":"Targeted gene disruption in mice with flow cytometry and gene expression analysis","pmids":["7542362"],"confidence":"High","gaps":["Did not define direct molecular targets","Did not establish DNA-binding mechanism"]},{"year":1995,"claim":"Defined the modular architecture of EBF1, showing how a novel zinc-coordination DNA-binding domain, an HLH-related dimerization domain, and an activation domain together enable sequence-specific transactivation.","evidence":"Mutational analysis with DNA-binding and transcriptional activation assays using heterologous domain fusions","pmids":["7796816"],"confidence":"High","gaps":["No structural model at this stage","C-terminal pioneer/phase-separation function not yet recognized"]},{"year":1997,"claim":"Demonstrated that EBF1 directly activates endogenous B-lineage target genes (surrogate light chains) in synergy with E2A, moving beyond requirement to direct gene control.","evidence":"Stable cDNA transfection in Ba/F3 cells with binding-site identification","pmids":["9252117"],"confidence":"High","gaps":["Synergy mechanism with E47 not resolved","Chromatin context not assessed"]},{"year":1998,"claim":"Placed E2A upstream of EBF1, ordering the transcription factor cascade of B-lineage specification.","evidence":"Ectopic E12 and EBF expression in a macrophage-like line with gene expression analysis","pmids":["9705952"],"confidence":"High","gaps":["Mechanism of E2A-driven Ebf1 induction not defined","Did not address feedback architecture"]},{"year":1999,"claim":"Identified Pax5 as a direct EBF1 target and demonstrated genetic collaboration between EBF1 and E2A, linking the two factors quantitatively in pro-B differentiation.","evidence":"Compound heterozygous mouse genetics with promoter binding and expression analysis","pmids":["10435576"],"confidence":"High","gaps":["Did not separate EBF1-dependent from Pax5-dependent commitment functions"]},{"year":1999,"claim":"Extended EBF1 function beyond hematopoiesis, showing it controls striatal neuronal differentiation, indicating a broadly redeployed differentiation-control role.","evidence":"Knockout mouse with in situ hybridization and histology","pmids":["10556054"],"confidence":"High","gaps":["Direct neuronal targets not identified","Mechanistic overlap with B-lineage function unknown"]},{"year":2003,"claim":"Showed EBF1 is instructive rather than permissive for B fate, since enforced expression restricts hematopoietic output almost exclusively to B cells.","evidence":"Retroviral transduction of progenitors with transplantation and flow cytometry","pmids":["12970188"],"confidence":"High","gaps":["Did not define the repressive targets enforcing fate restriction"]},{"year":2005,"claim":"Positioned IL-7R/STAT5 signaling upstream of EBF1 and showed EBF1 can substitute for IL-7R, integrating cytokine signaling into the transcriptional hierarchy.","evidence":"IL-7 and IL-7Ralpha knockout mice with retroviral EBF rescue and STAT5 experiments","pmids":["15837809","12811842"],"confidence":"High","gaps":["Quantitative contribution of STAT5 versus other inputs to Ebf1 induction unresolved"]},{"year":2008,"claim":"Established EBF1 as a dual activator/repressor that commits cells to B lineage partly independently of Pax5 by antagonizing C/EBPalpha, PU.1, and Id2.","evidence":"Conditional deletion plus ectopic expression with in vivo lineage and expression profiling","pmids":["18176567","18714008"],"confidence":"High","gaps":["Mechanism of alternative-lineage gene repression not defined at chromatin level"]},{"year":2009,"claim":"Revealed the chromatin-reprogramming mechanism: EBF1 increases accessibility and initiates DNA demethylation via SWI/SNF (Brg1/Brm), opposed by Mi-2/NuRD, priming targets for Pax5.","evidence":"Inducible EBF:ER/Pax5:ER systems with shRNA knockdown, accessibility and methylation assays","pmids":["19549820"],"confidence":"High","gaps":["Did not identify the EBF1 domain responsible for pioneering","Phase-separation basis not yet known"]},{"year":2009,"claim":"Demonstrated that EBF1-mediated repression of Id2 and Id3 is essential for B specification, and identified non-hematopoietic roles in the osteoblast/adipocyte balance and adipogenesis.","evidence":"In vivo rescue with Id overexpression; knockout histomorphometry; promoter activation and knockdown in adipocyte models","pmids":["19122139","19130908","17060461"],"confidence":"High","gaps":["Shared versus lineage-specific cofactors across tissues not defined"]},{"year":2010,"claim":"Provided high-resolution structural basis for DNA recognition, showing a pseudoimmunoglobulin/Rel-homology-related fold with a unique zinc knuckle and an atypical HLH dimerization motif.","evidence":"X-ray crystallography of the EBF1 dimer-DNA complex and isolated domains","pmids":["20876732","20592035"],"confidence":"High","gaps":["Structure of the C-terminal/prion-like region not determined","Did not address phase separation"]},{"year":2010,"claim":"Mapped EBF1 genome-wide in a regulatory network with E2A and Foxo1, linking factor occupancy to enhancer histone marks in pro-B cells.","evidence":"ChIP-seq with genome-wide regulatory element and histone modification analysis","pmids":["20543837"],"confidence":"High","gaps":["Direction of causality among the three factors not fully resolved here"]},{"year":2011,"claim":"Defined EBF1 as a positive feedback partner of FOXO1 and a controller of pro-B proliferation, survival, and mature B-cell signaling via direct targets including c-Myb and Bcl-xL.","evidence":"Conditional inactivation, reciprocal depletion, forced target expression, and genome-wide ChIP-seq/RNA analysis","pmids":["22431510","23213261"],"confidence":"High","gaps":["How the EBF1-FOXO1 loop is initiated remains unresolved"]},{"year":2012,"claim":"Showed EBF1 actively maintains commitment, since its loss in committed pro-B cells permits conversion to T and innate lymphoid cells, and identified Runx1-Cbfβ as an upstream epigenetic activator of Ebf1.","evidence":"Conditional deletion with lineage tracing and ChIP; conditional Runx1/Cbfβ deletion with reporter mutagenesis and retroviral rescue","pmids":["23812095","22665574","22473956"],"confidence":"High","gaps":["Mechanism keeping alternative-lineage genes silenced after commitment not fully defined"]},{"year":2013,"claim":"Identified the CCR4-NOT complex as a direct EBF1 partner (via CNOT3 at His240) coupling EBF1 to mRNA stability and autoregulation, and defined adipocyte-specific genome-wide EBF1 functions in insulin signaling.","evidence":"SILAC mass spectrometry, H240A mutagenesis, conditional Cnot3 knockout; adipocyte ChIP-seq with metabolic assays","pmids":["27807034","24174531","23569325"],"confidence":"High","gaps":["How EBF1 directs gene-specific mRNA stability via CCR4-NOT not mechanistically resolved"]},{"year":2016,"claim":"Localized pioneer function to the EBF1 C-terminal domain, which is required for de novo accessibility and demethylation at sites with limited co-occupancy by other factors.","evidence":"Genome-wide DNaseI HS, methylation, and ChIP-seq comparing EBF1wt and EBF1ΔC in Ebf1-/- progenitors","pmids":["26982363"],"confidence":"High","gaps":["Biophysical basis of CTD pioneering not yet known at this point"]},{"year":2018,"claim":"Demonstrated by time-resolved analysis that EBF1 occupancy precedes accessibility formation, formally establishing pioneer kinetics and a requirement for continuous EBF1 to maintain accessible domains.","evidence":"Inducible EBF1 in Ebf1-/- pre-pro-B cells with time-resolved ATAC-seq and ChIP-seq","pmids":["29440261"],"confidence":"High","gaps":["Did not resolve the molecular machinery converting binding to accessibility"]},{"year":2020,"claim":"Provided the biophysical mechanism of pioneering: the CTD prion-like domain drives phase separation enhanced by FUS and recruits Brg1 into condensates to stabilize chromatin occupancy.","evidence":"Phase separation assays, FUS/Brg1 Co-IP, live imaging, FRAP, and heterologous PLD rescue","pmids":["33159853","32066955"],"confidence":"High","gaps":["In vivo relevance of condensate formation at endogenous loci not fully quantified"]},{"year":2021,"claim":"Established Myc as a direct EBF1 target driving pro-B expansion through defined enhancers, and extended EBF1 roles to pericyte commitment.","evidence":"Chromosome conformation, ATAC/ChIP-seq, CRISPR-Cas9 enhancer mutagenesis, and rescue; pericyte siRNA knockdown","pmids":["33619557","34272603"],"confidence":"High","gaps":["Relative contribution of individual Myc enhancers in vivo not fully dissected"]},{"year":2024,"claim":"Acute degradation showed EBF1 acts predominantly as an activator inducing open chromatin, with largely unique targets, and revealed it promotes Igh locus loop extrusion by repressing Wapl.","evidence":"In vivo degron-based acute degradation with ATAC-seq, ChIP-seq, and RNA-seq across B-cell stages","pmids":["39179932"],"confidence":"High","gaps":["How EBF1 represses Wapl mechanistically not resolved","Stage-specific cofactor switching not defined"]},{"year":null,"claim":"How EBF1 condensate formation, cofactor selection (CCR4-NOT, Brg1, FUS), and activator-versus-repressor output are integrated to produce cell-type-specific programs across B cells, adipocytes, neurons, stroma, and tumors remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No unified model linking phase separation to gene-specific outcomes","Cross-tissue cofactor determinants unknown","Mechanism of context-dependent repression incompletely defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,2,4,13,22,39,43]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,18,19]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[37,42]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[31,35,37]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,4,22,39,43]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[15,31,35,37,43]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,14,22,27]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[5,12,17,40]}],"complexes":[],"partners":["E2A/E47","FOXO1","CNOT3","FUS","BRG1/SMARCA4","ZNF521","MEF2C","STAT5"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9UH73","full_name":"Transcription factor COE1","aliases":["Early B-cell factor"],"length_aa":591,"mass_kda":64.5,"function":"Key pioneer transcription factor of B-cell specification and commitment (PubMed:27807034). Recognizes variations of the palindromic sequence 5'-ATTCCCNNGGGAATT-3'. Operates in a transcription factor network to activate B-cell-specific genes and repress genes associated with alternative cell fates. For instance, positively regulates many B-cell specific genes including BCR or CD40 while repressing genes that direct cells into alternative lineages, including GATA3 and TCF7 for the T-cell lineage. In addition to its role during lymphopoiesis, controls the thermogenic gene program in adipocytes during development and in response to environmental cold (By similarity) (Microbial infection) Acts as a chromatin anchor for Epstein-Barr virus EBNA2 to mediate the assembly of EBNA2 chromatin complexes in B-cells (PubMed:28968461). In addition, binds to the viral LMP1 proximal promoter and promotes its expression during latency (PubMed:26819314)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9UH73/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/EBF1","classification":"Not Classified","n_dependent_lines":61,"n_total_lines":1208,"dependency_fraction":0.050496688741721855},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/EBF1","total_profiled":1310},"omim":[{"mim_id":"618696","title":"GOLGI-ASSOCIATED OLFACTORY SIGNALING REGULATOR; GFY","url":"https://www.omim.org/entry/618696"},{"mim_id":"615416","title":"BASIC HELIX-LOOP-HELIX FAMILY, MEMBER A9; BHLHA9","url":"https://www.omim.org/entry/615416"},{"mim_id":"613065","title":"LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL","url":"https://www.omim.org/entry/613065"},{"mim_id":"612176","title":"MYB-LIKE, SWIRM, AND MPN DOMAINS-CONTAINING PROTEIN 1; MYSM1","url":"https://www.omim.org/entry/612176"},{"mim_id":"607407","title":"EARLY B-CELL FACTOR 3; EBF3","url":"https://www.omim.org/entry/607407"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"adipose tissue","ntpm":35.4}],"url":"https://www.proteinatlas.org/search/EBF1"},"hgnc":{"alias_symbol":["OLF1","COE1"],"prev_symbol":["EBF"]},"alphafold":{"accession":"Q9UH73","domains":[{"cath_id":"2.60.40.3180","chopping":"35-234","consensus_level":"high","plddt":95.4051,"start":35,"end":234},{"cath_id":"2.60.40.10","chopping":"262-344","consensus_level":"medium","plddt":95.0245,"start":262,"end":344}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UH73","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UH73-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UH73-F1-predicted_aligned_error_v6.png","plddt_mean":70.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=EBF1","jax_strain_url":"https://www.jax.org/strain/search?query=EBF1"},"sequence":{"accession":"Q9UH73","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UH73.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UH73/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UH73"}},"corpus_meta":[{"pmid":"14675532","id":"PMC_14675532","title":"Plant responses to ethylene gas are mediated by SCF(EBF1/EBF2)-dependent proteolysis of EIN3 transcription factor.","date":"2003","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/14675532","citation_count":636,"is_preprint":false},{"pmid":"7542362","id":"PMC_7542362","title":"Failure of B-cell differentiation in mice lacking the transcription factor EBF.","date":"1995","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/7542362","citation_count":539,"is_preprint":false},{"pmid":"20543837","id":"PMC_20543837","title":"A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate.","date":"2010","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20543837","citation_count":413,"is_preprint":false},{"pmid":"10435576","id":"PMC_10435576","title":"Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A.","date":"1999","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/10435576","citation_count":250,"is_preprint":false},{"pmid":"9252117","id":"PMC_9252117","title":"EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes.","date":"1997","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/9252117","citation_count":205,"is_preprint":false},{"pmid":"18176567","id":"PMC_18176567","title":"Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5.","date":"2008","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18176567","citation_count":200,"is_preprint":false},{"pmid":"9705952","id":"PMC_9705952","title":"Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12.","date":"1998","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9705952","citation_count":190,"is_preprint":false},{"pmid":"17060461","id":"PMC_17060461","title":"Critical role for Ebf1 and Ebf2 in the adipogenic transcriptional cascade.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17060461","citation_count":183,"is_preprint":false},{"pmid":"15837809","id":"PMC_15837809","title":"IL-7 receptor signaling is necessary for stage transition in adult B cell development through up-regulation of EBF.","date":"2005","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15837809","citation_count":180,"is_preprint":false},{"pmid":"9151732","id":"PMC_9151732","title":"The characterization of the Olf-1/EBF-like HLH transcription factor family: implications in olfactory gene regulation and neuronal development.","date":"1997","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9151732","citation_count":180,"is_preprint":false},{"pmid":"10556054","id":"PMC_10556054","title":"Ebf1 controls early cell differentiation in the embryonic striatum.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10556054","citation_count":172,"is_preprint":false},{"pmid":"23812095","id":"PMC_23812095","title":"Transcription factor EBF1 is essential for the maintenance of B cell identity and prevention of alternative fates in committed cells.","date":"2013","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23812095","citation_count":168,"is_preprint":false},{"pmid":"15314643","id":"PMC_15314643","title":"Cellular immune response to parasitization in Drosophila requires the EBF orthologue collier.","date":"2004","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/15314643","citation_count":162,"is_preprint":false},{"pmid":"10882075","id":"PMC_10882075","title":"E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells.","date":"2000","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/10882075","citation_count":154,"is_preprint":false},{"pmid":"9389446","id":"PMC_9389446","title":"Family of Ebf/Olf-1-related genes potentially involved in neuronal differentiation and regional specification in the central nervous system.","date":"1997","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/9389446","citation_count":148,"is_preprint":false},{"pmid":"23863747","id":"PMC_23863747","title":"Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2.","date":"2013","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/23863747","citation_count":141,"is_preprint":false},{"pmid":"21606506","id":"PMC_21606506","title":"Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia.","date":"2011","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21606506","citation_count":135,"is_preprint":false},{"pmid":"22431510","id":"PMC_22431510","title":"Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells.","date":"2012","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/22431510","citation_count":135,"is_preprint":false},{"pmid":"26748855","id":"PMC_26748855","title":"Seedlings Transduce the Depth and Mechanical Pressure of Covering Soil Using COP1 and Ethylene to Regulate EBF1/EBF2 for Soil Emergence.","date":"2015","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/26748855","citation_count":122,"is_preprint":false},{"pmid":"11578857","id":"PMC_11578857","title":"The COE--Collier/Olf1/EBF--transcription factors: structural conservation and diversity of developmental functions.","date":"2001","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11578857","citation_count":120,"is_preprint":false},{"pmid":"14573522","id":"PMC_14573522","title":"Ebf gene function is required for coupling neuronal differentiation and cell cycle exit.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/14573522","citation_count":119,"is_preprint":false},{"pmid":"7796816","id":"PMC_7796816","title":"EBF contains a novel zinc coordination motif and multiple dimerization and transcriptional activation domains.","date":"1995","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/7796816","citation_count":119,"is_preprint":false},{"pmid":"19549820","id":"PMC_19549820","title":"Opposing effects of SWI/SNF and Mi-2/NuRD chromatin remodeling complexes on epigenetic reprogramming by EBF and Pax5.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19549820","citation_count":114,"is_preprint":false},{"pmid":"18714008","id":"PMC_18714008","title":"EBF1 is essential for B-lineage priming and establishment of a transcription factor network in common lymphoid progenitors.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18714008","citation_count":114,"is_preprint":false},{"pmid":"22473956","id":"PMC_22473956","title":"Essential role of EBF1 in the generation and function of distinct mature B cell types.","date":"2012","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22473956","citation_count":108,"is_preprint":false},{"pmid":"26872634","id":"PMC_26872634","title":"EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications.","date":"2016","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/26872634","citation_count":106,"is_preprint":false},{"pmid":"9501982","id":"PMC_9501982","title":"XCoe2, a transcription factor of the Col/Olf-1/EBF family involved in the specification of primary neurons in Xenopus.","date":"1998","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/9501982","citation_count":104,"is_preprint":false},{"pmid":"26982363","id":"PMC_26982363","title":"Pioneering Activity of the C-Terminal Domain of EBF1 Shapes the Chromatin Landscape for B Cell Programming.","date":"2016","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/26982363","citation_count":101,"is_preprint":false},{"pmid":"20861858","id":"PMC_20861858","title":"Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome.","date":"2010","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/20861858","citation_count":98,"is_preprint":false},{"pmid":"19996307","id":"PMC_19996307","title":"Emerging roles of the EBF family of transcription factors in tumor suppression.","date":"2009","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/19996307","citation_count":93,"is_preprint":false},{"pmid":"23213261","id":"PMC_23213261","title":"Positive intergenic feedback circuitry, involving EBF1 and FOXO1, orchestrates B-cell fate.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23213261","citation_count":87,"is_preprint":false},{"pmid":"24794633","id":"PMC_24794633","title":"Collier/OLF/EBF-dependent transcriptional dynamics control pharyngeal muscle specification from primed cardiopharyngeal progenitors.","date":"2014","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/24794633","citation_count":81,"is_preprint":false},{"pmid":"29440261","id":"PMC_29440261","title":"Dynamic EBF1 occupancy directs sequential epigenetic and transcriptional events in B-cell programming.","date":"2018","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/29440261","citation_count":76,"is_preprint":false},{"pmid":"19130908","id":"PMC_19130908","title":"Ebf1-dependent control of the osteoblast and adipocyte lineages.","date":"2008","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/19130908","citation_count":74,"is_preprint":false},{"pmid":"26468528","id":"PMC_26468528","title":"Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.","date":"2015","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/26468528","citation_count":72,"is_preprint":false},{"pmid":"12139918","id":"PMC_12139918","title":"Cloning of a novel Olf-1/EBF-like gene, O/E-4, by degenerate oligo-based direct selection.","date":"2002","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/12139918","citation_count":71,"is_preprint":false},{"pmid":"19122139","id":"PMC_19122139","title":"Ebf1-mediated down-regulation of Id2 and Id3 is essential for specification of the B cell lineage.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19122139","citation_count":69,"is_preprint":false},{"pmid":"19903730","id":"PMC_19903730","title":"Silencing Sl-EBF1 and Sl-EBF2 expression causes constitutive ethylene response phenotype, accelerated plant senescence, and fruit ripening in tomato.","date":"2009","source":"Journal of experimental botany","url":"https://pubmed.ncbi.nlm.nih.gov/19903730","citation_count":69,"is_preprint":false},{"pmid":"12970188","id":"PMC_12970188","title":"Enforced expression of EBF in hematopoietic stem cells restricts lymphopoiesis to the B cell lineage.","date":"2003","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12970188","citation_count":66,"is_preprint":false},{"pmid":"12077253","id":"PMC_12077253","title":"Cloning and characterization of a promoter flanking the early B cell factor (EBF) gene indicates roles for E-proteins and autoregulation in the control of EBF expression.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12077253","citation_count":66,"is_preprint":false},{"pmid":"33159853","id":"PMC_33159853","title":"A Prion-like Domain in Transcription Factor EBF1 Promotes Phase Separation and Enables B Cell Programming of Progenitor Chromatin.","date":"2020","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/33159853","citation_count":66,"is_preprint":false},{"pmid":"21652681","id":"PMC_21652681","title":"IL-7 mediates Ebf-1-dependent lineage restriction in early lymphoid progenitors.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21652681","citation_count":65,"is_preprint":false},{"pmid":"17825045","id":"PMC_17825045","title":"Selective expression of Knot/Collier, a transcriptional regulator of the EBF/Olf-1 family, endows the Drosophila sensory system with neuronal class-specific elaborated dendritic patterns.","date":"2007","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/17825045","citation_count":63,"is_preprint":false},{"pmid":"12811842","id":"PMC_12811842","title":"EBF-regulating Pax5 transcription is enhanced by STAT5 in the early stage of B cells.","date":"2003","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12811842","citation_count":61,"is_preprint":false},{"pmid":"9784615","id":"PMC_9784615","title":"Molecular cloning of Zcoe2, the zebrafish homolog of Xenopus Xcoe2 and mouse EBF-2, and its expression during primary neurogenesis.","date":"1998","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/9784615","citation_count":61,"is_preprint":false},{"pmid":"26150488","id":"PMC_26150488","title":"The EBF transcription factor Collier directly promotes Drosophila blood cell progenitor maintenance independently of the niche.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26150488","citation_count":57,"is_preprint":false},{"pmid":"26752713","id":"PMC_26752713","title":"EBNA2 Drives Formation of New Chromosome Binding Sites and Target Genes for B-Cell Master Regulatory Transcription Factors RBP-jκ and EBF1.","date":"2016","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/26752713","citation_count":56,"is_preprint":false},{"pmid":"12406913","id":"PMC_12406913","title":"Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12406913","citation_count":53,"is_preprint":false},{"pmid":"22472950","id":"PMC_22472950","title":"Lentiviral vector induced insertional haploinsufficiency of Ebf1 causes murine leukemia.","date":"2012","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/22472950","citation_count":52,"is_preprint":false},{"pmid":"15920012","id":"PMC_15920012","title":"Inhibition of EBF function by active Notch signaling reveals a novel regulatory pathway in early B-cell development.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15920012","citation_count":50,"is_preprint":false},{"pmid":"14994268","id":"PMC_14994268","title":"Expression of AmphiCoe, an amphioxus COE/EBF gene, in the developing central nervous system and epidermal sensory neurons.","date":"2004","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/14994268","citation_count":50,"is_preprint":false},{"pmid":"24174531","id":"PMC_24174531","title":"Early B-cell factor-1 (EBF1) is a key regulator of metabolic and inflammatory signaling pathways in mature adipocytes.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24174531","citation_count":47,"is_preprint":false},{"pmid":"22665574","id":"PMC_22665574","title":"Runx1-Cbfβ facilitates early B lymphocyte development by regulating expression of Ebf1.","date":"2012","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22665574","citation_count":46,"is_preprint":false},{"pmid":"20331442","id":"PMC_20331442","title":"Reduced EBF expression underlies loss of B-cell potential of hematopoietic progenitors with age.","date":"2010","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/20331442","citation_count":45,"is_preprint":false},{"pmid":"24786561","id":"PMC_24786561","title":"Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24786561","citation_count":45,"is_preprint":false},{"pmid":"23775715","id":"PMC_23775715","title":"A capture-sequencing strategy identifies IRF8, EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23775715","citation_count":44,"is_preprint":false},{"pmid":"20385820","id":"PMC_20385820","title":"Compound haploinsufficiencies of Ebf1 and Runx1 genes impede B cell lineage progression.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20385820","citation_count":43,"is_preprint":false},{"pmid":"34791491","id":"PMC_34791491","title":"F-box protein EBF1 and transcription factor ABI5-like regulate banana fruit chilling-induced ripening disorder.","date":"2022","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/34791491","citation_count":42,"is_preprint":false},{"pmid":"28978690","id":"PMC_28978690","title":"Aryl Hydrocarbon Receptor Activation Suppresses EBF1 and PAX5 and Impairs Human B Lymphopoiesis.","date":"2017","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/28978690","citation_count":42,"is_preprint":false},{"pmid":"20876732","id":"PMC_20876732","title":"Structure of an Ebf1:DNA complex reveals unusual DNA recognition and structural homology with Rel proteins.","date":"2010","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/20876732","citation_count":42,"is_preprint":false},{"pmid":"25271088","id":"PMC_25271088","title":"Gene by stress genome-wide interaction analysis and path analysis identify EBF1 as a cardiovascular and metabolic risk gene.","date":"2014","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/25271088","citation_count":42,"is_preprint":false},{"pmid":"16143323","id":"PMC_16143323","title":"The UNC-3 Olf/EBF protein represses alternate neuronal programs to specify chemosensory neuron identity.","date":"2005","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16143323","citation_count":38,"is_preprint":false},{"pmid":"14594818","id":"PMC_14594818","title":"CD40 stimulation induces Pax5/BSAP and EBF activation through a APE/Ref-1-dependent redox mechanism.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14594818","citation_count":38,"is_preprint":false},{"pmid":"26056231","id":"PMC_26056231","title":"Combined heterozygous loss of Ebf1 and Pax5 allows for T-lineage conversion of B cell progenitors.","date":"2015","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26056231","citation_count":38,"is_preprint":false},{"pmid":"23569325","id":"PMC_23569325","title":"Coordinated transcriptional regulation of bone homeostasis by Ebf1 and Zfp521 in both mesenchymal and hematopoietic lineages.","date":"2013","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23569325","citation_count":38,"is_preprint":false},{"pmid":"12457614","id":"PMC_12457614","title":"Roles of EBF and Pax-5 in B lineage commitment and development.","date":"2002","source":"Seminars in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12457614","citation_count":37,"is_preprint":false},{"pmid":"29336845","id":"PMC_29336845","title":"Defining B Cell Chromatin: Lessons from EBF1.","date":"2018","source":"Trends in genetics : TIG","url":"https://pubmed.ncbi.nlm.nih.gov/29336845","citation_count":37,"is_preprint":false},{"pmid":"25838350","id":"PMC_25838350","title":"Ebf1 heterozygosity results in increased DNA damage in pro-B cells and their synergistic transformation by Pax5 haploinsufficiency.","date":"2015","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25838350","citation_count":36,"is_preprint":false},{"pmid":"21839736","id":"PMC_21839736","title":"EBF proteins participate in transcriptional regulation of Xenopus muscle development.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21839736","citation_count":34,"is_preprint":false},{"pmid":"26900922","id":"PMC_26900922","title":"MEF2C and EBF1 Co-regulate B Cell-Specific Transcription.","date":"2016","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26900922","citation_count":33,"is_preprint":false},{"pmid":"23174882","id":"PMC_23174882","title":"Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma.","date":"2012","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/23174882","citation_count":33,"is_preprint":false},{"pmid":"32066955","id":"PMC_32066955","title":"EBF1-deficient bone marrow stroma elicits persistent changes in HSC potential.","date":"2020","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32066955","citation_count":32,"is_preprint":false},{"pmid":"33619557","id":"PMC_33619557","title":"EBF1 and PAX5 control pro-B cell expansion via opposing regulation of the Myc gene.","date":"2021","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/33619557","citation_count":32,"is_preprint":false},{"pmid":"28137879","id":"PMC_28137879","title":"Differentiation of human telencephalic progenitor cells into MSNs by inducible expression of Gsx2 and Ebf1.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28137879","citation_count":32,"is_preprint":false},{"pmid":"21529371","id":"PMC_21529371","title":"EBF factors drive expression of multiple classes of target genes governing neuronal development.","date":"2011","source":"Neural development","url":"https://pubmed.ncbi.nlm.nih.gov/21529371","citation_count":31,"is_preprint":false},{"pmid":"21469119","id":"PMC_21469119","title":"A dose-dependent role for EBF1 in repressing non-B-cell-specific genes.","date":"2011","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21469119","citation_count":31,"is_preprint":false},{"pmid":"32087328","id":"PMC_32087328","title":"TMPO-AS1/miR-98-5p/EBF1 feedback loop contributes to the progression of bladder cancer.","date":"2020","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32087328","citation_count":30,"is_preprint":false},{"pmid":"35857872","id":"PMC_35857872","title":"EBNA2-EBF1 complexes promote MYC expression and metabolic processes driving S-phase progression of Epstein-Barr virus-infected B cells.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/35857872","citation_count":29,"is_preprint":false},{"pmid":"12007494","id":"PMC_12007494","title":"Impact of targeted vector design on Co/E1 plasmid replication.","date":"2002","source":"Trends in biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/12007494","citation_count":29,"is_preprint":false},{"pmid":"29181981","id":"PMC_29181981","title":"Comprehensive Proteomic Investigation of Ebf1 Heterozygosity in Pro-B Lymphocytes Utilizing Data Independent Acquisition.","date":"2017","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/29181981","citation_count":29,"is_preprint":false},{"pmid":"35182476","id":"PMC_35182476","title":"EBF1 nuclear repositioning instructs chromatin refolding to promote therapy resistance in T leukemic cells.","date":"2022","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/35182476","citation_count":28,"is_preprint":false},{"pmid":"15580294","id":"PMC_15580294","title":"Evi3, a zinc-finger protein related to EBFAZ, regulates EBF activity in B-cell leukemia.","date":"2005","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15580294","citation_count":28,"is_preprint":false},{"pmid":"27802138","id":"PMC_27802138","title":"Rewiring of an ancestral Tbx1/10-Ebf-Mrf network for pharyngeal muscle specification in distinct embryonic lineages.","date":"2016","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/27802138","citation_count":28,"is_preprint":false},{"pmid":"28968461","id":"PMC_28968461","title":"EBF1 binds to EBNA2 and promotes the assembly of EBNA2 chromatin complexes in B cells.","date":"2017","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/28968461","citation_count":28,"is_preprint":false},{"pmid":"34272603","id":"PMC_34272603","title":"EBF1 is expressed in pericytes and contributes to pericyte cell commitment.","date":"2021","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/34272603","citation_count":27,"is_preprint":false},{"pmid":"36321994","id":"PMC_36321994","title":"Brassinosteroids promote etiolated apical structures in darkness by amplifying the ethylene response via the EBF-EIN3/PIF3 circuit.","date":"2023","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/36321994","citation_count":27,"is_preprint":false},{"pmid":"27807034","id":"PMC_27807034","title":"Interaction of CCR4-NOT with EBF1 regulates gene-specific transcription and mRNA stability in B lymphopoiesis.","date":"2016","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/27807034","citation_count":27,"is_preprint":false},{"pmid":"26788497","id":"PMC_26788497","title":"ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies.","date":"2015","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/26788497","citation_count":25,"is_preprint":false},{"pmid":"15261831","id":"PMC_15261831","title":"Expression patterns of the coe/ebf transcription factor genes during chicken and mouse limb development.","date":"2004","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/15261831","citation_count":25,"is_preprint":false},{"pmid":"20561923","id":"PMC_20561923","title":"Subtilase cytotoxin induces apoptosis in HeLa cells by mitochondrial permeabilization via activation of Bax/Bak, independent of C/EBF-homologue protein (CHOP), Ire1alpha or JNK signaling.","date":"2010","source":"Microbial pathogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/20561923","citation_count":25,"is_preprint":false},{"pmid":"20592035","id":"PMC_20592035","title":"Structural determination of functional domains in early B-cell factor (EBF) family of transcription factors reveals similarities to Rel DNA-binding proteins and a novel dimerization motif.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20592035","citation_count":25,"is_preprint":false},{"pmid":"28555080","id":"PMC_28555080","title":"Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesis.","date":"2017","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/28555080","citation_count":24,"is_preprint":false},{"pmid":"33004416","id":"PMC_33004416","title":"EBF1 and Pax5 safeguard leukemic transformation by limiting IL-7 signaling, Myc expression, and folate metabolism.","date":"2020","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/33004416","citation_count":24,"is_preprint":false},{"pmid":"35867755","id":"PMC_35867755","title":"EBF1 promotes triple-negative breast cancer progression by surveillance of the HIF1α pathway.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/35867755","citation_count":24,"is_preprint":false},{"pmid":"30658714","id":"PMC_30658714","title":"An ancient role for collier/Olf/Ebf (COE)-type transcription factors in axial motor neuron development.","date":"2019","source":"Neural development","url":"https://pubmed.ncbi.nlm.nih.gov/30658714","citation_count":24,"is_preprint":false},{"pmid":"24068669","id":"PMC_24068669","title":"Ebf1 and c-Myb repress rag transcription downstream of Stat5 during early B cell development.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24068669","citation_count":23,"is_preprint":false},{"pmid":"31405952","id":"PMC_31405952","title":"Early B Cell Factor 1 (EBF1) Regulates Glomerular Development by Controlling Mesangial Maturation and Consequently COX-2 Expression.","date":"2019","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/31405952","citation_count":22,"is_preprint":false},{"pmid":"32329523","id":"PMC_32329523","title":"Long intergenic noncoding RNA 00844 promotes apoptosis and represses proliferation of prostate cancer cells through upregulating GSTP1 by recruiting EBF1.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32329523","citation_count":22,"is_preprint":false},{"pmid":"29191698","id":"PMC_29191698","title":"MicroRNAs-361-5p and miR-574-5p associate with human adipose morphology and regulate EBF1 expression in white adipose tissue.","date":"2017","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/29191698","citation_count":22,"is_preprint":false},{"pmid":"39179932","id":"PMC_39179932","title":"Transcriptional function of E2A, Ebf1, Pax5, Ikaros and Aiolos analyzed by in vivo acute protein degradation in early B cell development.","date":"2024","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/39179932","citation_count":21,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45634,"output_tokens":10195,"usd":0.144914,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20633,"output_tokens":5849,"usd":0.124695,"stage2_stop_reason":"end_turn"},"total_usd":0.269609,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"EBF (EBF1) is required for B cell differentiation; targeted gene disruption in mice shows EBF-deficient mice lack B cells with rearranged immunoglobulin D and JH gene segments but contain B220+CD43+ progenitor cells, placing EBF function at a stage before Ig gene rearrangement but after B-lymphoid commitment.\",\n      \"method\": \"Targeted gene disruption (knockout mouse), flow cytometry, gene expression analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout with defined cellular phenotype, foundational study replicated by subsequent work\",\n      \"pmids\": [\"7542362\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"EBF contains a novel zinc coordination motif (H-X3-C-X2-C-X5-C) in its DNA-binding domain critical for DNA recognition, a C-terminal helix-loop-helix-related dimerization domain, and a serine/threonine-rich transcriptional activation domain; the DNA-binding domain alone can mediate both dimerization on optimized half-sites and transcriptional activation.\",\n      \"method\": \"Mutational analysis, DNA-binding assays, transcriptional activation assays with heterologous domain fusions\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis with functional validation, replicated by structural work\",\n      \"pmids\": [\"7796816\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"EBF and E47 synergize to induce expression of the endogenous immunoglobulin surrogate light chain genes lambda5 and VpreB in Ba/F3 hematopoietic cells; multiple functional EBF and E47 binding sites were identified in the lambda5 promoter/enhancer, establishing lambda5 as a direct genetic target.\",\n      \"method\": \"Stable transfection of cDNAs encoding EBF or E47 into Ba/F3 cells, endogenous gene expression analysis, binding site identification\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct activation of endogenous target genes demonstrated with binding site identification, replicated by later work\",\n      \"pmids\": [\"9252117\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"E2A protein E12 induces EBF expression in a macrophage-like cell line, and EBF alone activates a subset of B lineage genes, placing E2A upstream of EBF in the transcriptional hierarchy of B cell lineage specification.\",\n      \"method\": \"Ectopic expression of E12 and EBF in 70Z/3-derived macrophage line, gene expression analysis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — epistasis established by ectopic expression in defined cellular context, replicated across multiple subsequent studies\",\n      \"pmids\": [\"9705952\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"EBF directly binds and activates the Pax5 promoter; genetic collaboration between EBF and E2A is demonstrated by Ebf+/- E2a+/- compound heterozygous mice showing stronger defects in pro-B cell differentiation than single mutants, with reduced Pax5, Rag1, Rag2, and mb-1 expression.\",\n      \"method\": \"Compound heterozygous mouse genetics, promoter binding assays, gene expression analysis\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct promoter binding plus genetic epistasis, replicated by subsequent studies\",\n      \"pmids\": [\"10435576\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Ebf1 controls cell differentiation in the murine embryonic striatum; Ebf1 targeted disruption causes failure to downregulate SVZ-restricted genes and failure to activate mantle-specific genes in postmitotic cells, followed by increased cell death and dramatic reduction in postnatal striatum size.\",\n      \"method\": \"Targeted gene disruption (knockout mouse), in situ hybridization, histological analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout with defined molecular and cellular phenotype in neuronal context\",\n      \"pmids\": [\"10556054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"EBF promotes VlambdaIII-Jlambda1 recombination in non-lymphoid embryonic kidney cells when co-expressed with RAG1/RAG2, while E2A (but not EBF) activates IgK VK1J rearrangement; either E2A or EBF can activate IgH DH4J recombination, demonstrating distinct and partially overlapping roles in V(D)J recombination.\",\n      \"method\": \"Transfection of E2A, EBF, RAG1/RAG2 into embryonic kidney cells, PCR-based detection of recombination products\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct functional assay in non-lymphoid cells, single lab\",\n      \"pmids\": [\"10882075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The EBF gene promoter contains functional binding sites for E-proteins (E47 activates the promoter) and for EBF itself, establishing an autoregulatory loop; a tissue-restricted factor also binds an upstream regulatory region in B-lineage cells.\",\n      \"method\": \"Primer extension, reporter gene assays, EMSA, transfection assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct DNA binding and functional reporter assays, single lab\",\n      \"pmids\": [\"12077253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Enforced expression of EBF in hematopoietic stem cells restricts lymphopoiesis almost exclusively to the B cell lineage at the expense of T cells, NK cells, and lymphoid dendritic cells, demonstrating an instructive role for EBF in B cell fate specification.\",\n      \"method\": \"Retroviral transduction of EBF into hematopoietic progenitors, bone marrow transplantation, flow cytometric analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — gain-of-function with clear lineage restriction phenotype, consistent with loss-of-function data\",\n      \"pmids\": [\"12970188\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"STAT5 (phosphorylated downstream of IL-7 receptor) binds to the EBF-binding site in the Pax5 promoter (SBM) and enhances EBF-mediated transcription of Pax5, providing a direct mechanistic link between IL-7R signaling and Pax5 expression via EBF.\",\n      \"method\": \"Reporter gene assays, EMSA, chromatin immunoprecipitation\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assays in a pre-B cell line, single lab\",\n      \"pmids\": [\"12811842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"IL-7 receptor signaling upregulates EBF expression (via STAT5 activation) in pre-pro-B cells, and enforced EBF expression partially rescues B cell development in IL-7Ralpha-/- mice, placing IL-7R signaling upstream of EBF in the transcriptional hierarchy.\",\n      \"method\": \"IL-7 knockout and IL-7Ralpha knockout mouse analysis, retroviral EBF transduction, STAT5 activation experiments, in vivo rescue\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with in vivo rescue, multiple orthogonal approaches\",\n      \"pmids\": [\"15837809\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Notch signaling (Notch1-IC or Delta4 ligand-induced) inhibits EBF function by reducing EBF DNA-binding activity, thereby down-regulating EBF-regulated promoters; this provides a mechanism by which Notch promotes T cell fate over B cell fate by targeting both EBF and E2A.\",\n      \"method\": \"Transient transfection of Notch1-IC into pre-B cell line, reporter assays, DNA-binding assays, ligand stimulation of endogenous Notch receptors\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional reporter assays and DNA-binding assays, single lab\",\n      \"pmids\": [\"15920012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Ebf1 promotes adipogenesis by directly activating the PPARgamma1 promoter and the C/EBPalpha promoter; Ebf1 itself is induced by C/EBPbeta and delta binding its promoter; knockdown of Ebf1 and Ebf2 by shRNA blocks 3T3-L1 differentiation, establishing a critical role for Ebf1 within the adipogenic transcriptional cascade.\",\n      \"method\": \"Overexpression in NIH 3T3 fibroblasts, shRNA knockdown in 3T3-L1 cells, promoter binding assays, reporter assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct promoter activation and loss-of-function with defined phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"17060461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"EBF restricts alternative lineage options (myeloid, T lineage) and promotes B cell fate commitment independently of Pax5; ectopic EBF in multipotent progenitors directs B cell generation, antagonizes C/EBPalpha, PU.1 and Id2 expression, and sustained EBF expression in Pax5-/- pro-B cells is sufficient to repress myeloid and T lineage genes.\",\n      \"method\": \"Conditional deletion of EBF, ectopic expression in multipotential progenitors, in vivo lineage fate analysis, gene expression profiling\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — combined gain- and loss-of-function with clear lineage fate phenotypes\",\n      \"pmids\": [\"18176567\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"EBF1 is required for B-lineage priming in common lymphoid progenitors (CLPs); EBF1-deficient CLPs show no B lineage gene transcription and lack IgH chain recombination; Pax5, Pou2af1 (OcaB), and FoxO1 promoters contain functional EBF1 binding sites, establishing them as direct EBF1 target genes.\",\n      \"method\": \"Bone marrow transplantation of EBF1-deficient fetal liver cells, gene expression analysis, promoter binding site validation\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-autonomous analysis with direct binding site validation, multiple targets\",\n      \"pmids\": [\"18714008\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"EBF reprograms mb-1 (Ig-alpha) promoters by increasing chromatin accessibility and initiating DNA demethylation, facilitating subsequent promoter activation by Pax5. SWI/SNF ATPases (Brg1/Brm) are required for transcriptional activation by EBF, while Mi-2/NuRD complex (Mi-2beta) opposes EBF by maintaining hypermethylated chromatin; knockdown of Mi-2beta greatly enhances chromatin accessibility and mb-1 transcription in response to EBF.\",\n      \"method\": \"Inducible EBF:ER and Pax5:ER fusion systems, shRNA knockdown of Brg1/Brm and Mi-2beta, chromatin accessibility assays, DNA methylation analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods including chromatin remodeling assays and DNA methylation, rigorous controls\",\n      \"pmids\": [\"19549820\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Ebf1-mediated downregulation of both Id2 and Id3 is essential for B cell lineage specification; enforced Ebf1 expression in IL-7Ralpha-/- bone marrow potently downregulates Id2 and Id3 mRNA and restores B cell differentiation in vivo; overexpression of either Id2 or Id3 in wild-type bone marrow blocks B cell specification at the prepro-B cell stage.\",\n      \"method\": \"Retroviral transduction of Ebf1 in IL-7Ralpha-/- bone marrow, in vivo rescue, Id2/Id3 overexpression\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo rescue with clear molecular mechanism, loss- and gain-of-function\",\n      \"pmids\": [\"19122139\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Ebf1 plays a role in regulating both the osteoblast and adipocyte lineages in vivo; Ebf1-/- mice show increased osteoblast numbers, bone formation parameters, and serum osteocalcin, as well as dramatically increased adipocyte numbers in bone marrow; Ebf1-deficient mice display features of lipodystrophy.\",\n      \"method\": \"Ebf1 knockout mouse analysis, histomorphometry, serum markers, histology\",\n      \"journal\": \"Bone\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout with multiple defined phenotypic readouts across two cell lineages\",\n      \"pmids\": [\"19130908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The crystal structure of Ebf1 dimer bound to its palindromic recognition site reveals a pseudoimmunoglobulin-like fold with structural similarity to Rel homology domains of NFAT and NF-κB; each Ebf1 monomer contacts both palindromic half-sites via two loop-based modules and a unique Zn coordination motif, generating an extended contact area.\",\n      \"method\": \"X-ray crystallography\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with high-resolution structural determination\",\n      \"pmids\": [\"20876732\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Crystal structures of EBF family protein domains reveal: (1) DNA-binding domain resembling Rel homology superfamily but containing a unique zinc knuckle; (2) an IPT/TIG domain; (3) an atypical helix-loop-helix domain with a novel dimerization motif.\",\n      \"method\": \"X-ray crystallography of structured domains\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple crystal structures, structural determination of functional domains\",\n      \"pmids\": [\"20592035\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"E2A and EBF1 bind regulatory elements in the Foxo1 locus; E2A and EBF1, as well as E2A and Foxo1, are wired together by cis-regulatory sequences; E47 occupancy directly results in H3K4 monomethylation across enhancer regions, establishing a positive regulatory network among E2A, EBF1, and Foxo1 in pro-B cells.\",\n      \"method\": \"ChIP-seq, genome-wide analysis of regulatory elements, histone modification analysis\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide ChIP-seq with multiple orthogonal methods\",\n      \"pmids\": [\"20543837\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"EBF1 identifies the TET2 interaction partner; ChIP and western blotting show EBF1 interacts with TET2, suggesting a sequence-specific mechanism for TET2-mediated DNA demethylation.\",\n      \"method\": \"Chromatin immunoprecipitation, western blotting, sequence motif analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single ChIP/western blot, single lab, limited mechanistic follow-up\",\n      \"pmids\": [\"23863747\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"EBF1 is required for proliferation and survival of pro-B cells, and for signaling and function of peripheral B-cell subsets including B1 cells and marginal zone B cells; EBF1 targets c-Myb and Bcl-xL rescue survival defects; in mature B cells, EBF1 deficiency impairs BAFF-R and BCR-dependent Akt signaling; EBF1 is required for germinal center formation and class switch recombination.\",\n      \"method\": \"Conditional Ebf1 inactivation, v-Abl transformation, forced expression of EBF1 targets, genome-wide ChIP-seq and RNA analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout with multiple defined phenotypic readouts and genome-wide analysis\",\n      \"pmids\": [\"22431510\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"EBF1 and FOXO1 act in a positive intergenic feedback circuitry; depletion of EBF1 severely reduces FOXO1 mRNA abundance in LY6D+ CLPs, and depletion of FOXO1 ablates EBF1 transcript levels; their transcriptional signatures in deficient cells are strikingly similar, indicating a common set of target genes.\",\n      \"method\": \"EBF1 and FOXO1 knockout mouse analysis, genome-wide transcription factor occupancy (ChIP-seq), transcriptome analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal genetic depletion with genome-wide occupancy data\",\n      \"pmids\": [\"23213261\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Ebf1 represses Rag transcription in pro-B cells downstream of Stat5/IL-7R signaling; Ebf1 directly regulates c-Myb, which also represses Rag; Ebf1 and c-Myb antagonize Foxo1 binding to the Rag locus; Ebf1 directly represses Foxo1 expression and directly activates Gfi1b expression.\",\n      \"method\": \"shRNA knockdown, chromatin immunoprecipitation, gene expression analysis in Abelson-transformed B cells\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and shRNA knockdown, single lab, cell line model\",\n      \"pmids\": [\"24068669\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Conditional deletion of Ebf1 in committed pro-B cells causes their conversion into innate lymphoid cells and T cells; EBF1 directly binds and represses Id2 and TCF-1 genes; both EBF1 and Pax5 are required for B lineage commitment by repressing distinct and common determinants of alternative cell fates.\",\n      \"method\": \"Conditional Ebf1 deletion in committed pro-B cells, lineage tracing, ChIP, gene expression analysis\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional deletion with defined molecular targets (ChIP) and lineage conversion phenotype\",\n      \"pmids\": [\"23812095\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Runx1-Cbfβ complexes bind the Ebf1 proximal promoter and are required for its epigenetic activation (Runx1-binding motifs are essential for reporter expression; Runx1-deficient pro-B cells have excessive H3K27 trimethylation at the Ebf1 proximal promoter); retroviral Ebf1 (but not Pax5) transduction into Runx1-deficient progenitors restores B cell development, establishing Runx1-Cbfβ as an upstream activator of Ebf1.\",\n      \"method\": \"Conditional Runx1/Runx3/Cbfβ deletion, ChIP, reporter assay, retroviral rescue\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct promoter binding with mutagenesis, epigenetic analysis, and in vivo rescue\",\n      \"pmids\": [\"22665574\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"EBF1 is essential for B cell commitment, pro-B to pre-B cell transition, and for generation of marginal zone, B-1, follicular and germinal center B cells; BCR activation results in impaired intracellular signaling in EBF1-deficient follicular B cells; ectopic EBF1 expression efficiently induces B-1 cell development at the expense of conventional B cells.\",\n      \"method\": \"Conditional mutagenesis, BCR signaling assays, ChIP-seq, RNA-seq\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout with genome-wide analysis and gain-of-function\",\n      \"pmids\": [\"22473956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"EBF1 in mature adipocytes directly regulates components of PI3K/AKT, MAPK, and STAT1 signaling pathways; EBF1 knockdown significantly reduces insulin-stimulated glucose uptake and lipogenesis; genome-wide EBF1 occupies ~35,000 sites in adipocytes, mostly at enhancers, with cell-type-specific patterns distinct from B cells.\",\n      \"method\": \"EBF1 knockdown, transcriptional profiling, ChIP-seq, glucose uptake and lipogenesis assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide ChIP-seq combined with functional metabolic assays\",\n      \"pmids\": [\"24174531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Zfp521 physically interacts with EBF1 and represses its transcriptional activity; deletion of Zfp521 leads to increased Ebf1 activity in osteoblasts and osteoclasts; the bone phenotype of Zfp521+/- mice is rescued in Zfp521+/-:Ebf1+/- mice, establishing a Zfp521-EBF1 rheostat for bone homeostasis.\",\n      \"method\": \"Co-immunoprecipitation, conditional deletion, genetic rescue (double heterozygotes), transcriptional assays\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — physical interaction plus genetic epistasis with in vivo rescue\",\n      \"pmids\": [\"23569325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"EBF1 heterozygosity results in increased DNA damage in pro-B cells and reduced expression of DNA repair genes including Rad51; ChIP data indicate Rad51 is a direct EBF1 target; combined heterozygous mutations in Ebf1 and Pax5 dramatically increase pro-B cell leukemia frequency in mice.\",\n      \"method\": \"Gene expression analysis, ChIP, DNA damage assays (UV), mouse leukemia model\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP for direct target identification, functional DNA repair assays, single lab\",\n      \"pmids\": [\"25838350\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The EBF1 C-terminal domain (CTD) is required for a specific set of B-lineage genes and promotes de novo chromatin accessibility and DNA demethylation in previously naive chromatin (pioneer function); the CTD enables EBF1 to bind inaccessible genomic regions with limited co-occupancy by other transcription factors, whereas it is dispensable for binding at regions occupied by multiple transcription factors.\",\n      \"method\": \"Genome-wide DNaseI hypersensitivity, DNA methylation analysis, ChIP-seq, comparison of EBF1wt and EBF1ΔC-expressing Ebf1-/- progenitor cells\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide chromatin accessibility and methylation with domain-specific mutant, multiple orthogonal methods\",\n      \"pmids\": [\"26982363\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CCR4-NOT complex interacts with EBF1; CNOT3 directly interacts with EBF1 at histidine 240 (H240A mutation disrupts this); the EBF1–CCR4-NOT interaction regulates gene-specific transcription and mRNA stability; mice with conditional Cnot3 inactivation phenocopy the block in early B cell differentiation, associated with impaired EBF1 autoregulation and reduced pre-BCR component expression.\",\n      \"method\": \"SILAC-based mass spectrometry of EBF1-associated proteins, mutagenesis (H240A), complementation of Ebf1-/- progenitors, conditional Cnot3 knockout, gene expression analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mass spectrometry identification, mutagenesis, and conditional knockout with multiple orthogonal methods\",\n      \"pmids\": [\"27807034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"MEF2C and EBF1 co-regulate a subset of B cell-specific genes at shared binding sites; MEF2C interacts with HDAC7 to repress myeloid transcription programs; the p38 MAPK pathway activates MEF2C to drive B cell differentiation.\",\n      \"method\": \"Genome-wide MEF2C and EBF1 ChIP-seq, Mef2c knockout mouse, co-immunoprecipitation\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide ChIP-seq and Co-IP, single lab\",\n      \"pmids\": [\"26900922\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"EBF1 binds EBNA2 via EBNA2's N-terminal domain; EBF1 promotes assembly of EBNA2 chromatin complexes at CBF1-independent binding sites in B cells; EBNA2 exploits EBF1 to support metabolic processes and cell cycle progression (S-phase) in EBV-infected B cells, with the α1-helix of EBNA2's END domain promoting EBF1 binding.\",\n      \"method\": \"Co-immunoprecipitation, ChIP-seq, CBF1-deficient B cell analysis, EBV mutant analysis\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-immunoprecipitation, ChIP-seq, and EBV mutant functional analysis\",\n      \"pmids\": [\"28968461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"EBF1 functions as a pioneer transcription factor: in a time-resolved analysis, EBF1 occupancy precedes formation of chromatin accessibility; EBF1 also transiently occupies lineage-inappropriate genes prior to their silencing in pro-B cells; continuous EBF1 function is required for Cd79a promoter activity and maintenance of an accessible chromatin domain.\",\n      \"method\": \"Inducible EBF1 expression system in Ebf1-/- pre-pro-B cells, time-resolved ATAC-seq, ChIP-seq, gene expression analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — inducible system with time-resolved chromatin and transcription analysis, multiple orthogonal methods\",\n      \"pmids\": [\"29440261\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"EBF1 regulates glomerular development through its actions in Foxd1+ stromal/mesangial progenitor cells; EBF1 deficiency in Foxd1-lineage cells impairs calcineurin/NFATc1 activation and decreases COX-2 expression; overexpressing COX-2 in EBF1-deficient mice partially restores glomerular development.\",\n      \"method\": \"Conditional Ebf1 deletion (Foxd1-cre, Podocin-cre), COX-2 overexpression rescue, signaling pathway analysis\",\n      \"journal\": \"Journal of the American Society of Nephrology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional knockout with partial molecular rescue, single lab\",\n      \"pmids\": [\"31405952\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"EBF1's C-terminal domain (CTD) harbors a prion-like domain (PLD) capable of liquid-liquid phase separation, which is enhanced by interaction with the RNA-binding protein FUS; the CTD stabilizes EBF1 chromatin occupancy via recruitment of the chromatin remodeler Brg1; Brg1 partitions into phase-separated FUS condensates and co-localizes with EBF1 and FUS foci in pro-B cells; heterologous PLDs can confer pioneering function on EBF1ΔCTD.\",\n      \"method\": \"Phase separation assays, co-immunoprecipitation of FUS and Brg1, live-cell imaging, FRAP, heterologous domain rescue\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — biochemical reconstitution of phase separation, structural domain analysis, and functional rescue with multiple methods\",\n      \"pmids\": [\"33159853\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Conditional deletion of Ebf1 in bone marrow mesenchymal stromal cells (CAR cells/PαS cells) alters their cellular composition, chromatin structure, and gene expression (including reduced adhesion-related genes), impairs HSC adhesion leading to reduced HSC quiescence and diminished myeloid output, and causes persistent changes in HSC chromatin structure that persist through serial transplantations.\",\n      \"method\": \"Conditional Ebf1 deletion in MSCs, single-cell analysis, ATAC-seq, serial transplantation\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional deletion with single-cell and chromatin analysis, serial transplantation\",\n      \"pmids\": [\"32066955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"EBF1 directly activates Myc expression through six EBF1-responsive enhancer elements within the Myc locus, with one element of key importance identified by CRISPR-Cas9 targeting of EBF1-binding sites; PAX5, in contrast, represses Myc expression; ectopic MYC partially rescues B-cell expansion in EBF1-deficient cells, establishing Myc as a direct EBF1 target in pro-B-cell expansion.\",\n      \"method\": \"Chromosome conformation analysis, ATAC-seq, ChIP-seq, reporter assays, CRISPR-Cas9 mutagenesis, in vivo and in vitro rescue\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — CRISPR-Cas9 mutagenesis of binding sites, multiple chromatin methods, and functional rescue\",\n      \"pmids\": [\"33619557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"EBF1 is expressed in pericytes and contributes to pericyte cell commitment; EBF1 silencing in human brain vascular pericytes reduces PDGFRβ, CD146, VEGF, angiopoietin-1, NG2, and TGF-β expression but not CD90, a mesenchymal marker.\",\n      \"method\": \"Immunohistochemistry, RT-qPCR, FACS, EBF1 siRNA knockdown in human pericytes\",\n      \"journal\": \"Histochemistry and cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — knockdown with defined phenotype in primary cells, replicated across cell types\",\n      \"pmids\": [\"34272603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"EBF1 drives triple-negative breast cancer tumorigenicity by assembling a transcriptional complex with HIF1α that suppresses p300 activity, thereby fine-tuning HIF1α target gene expression and preventing excessive mitophagy-induced cell death; EBF1 depletion induces extensive cell mitophagy.\",\n      \"method\": \"EBF1 depletion, genome-wide ChIP-seq, co-immunoprecipitation, mitophagy assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq and Co-IP for complex identification, functional mitophagy assays, single lab\",\n      \"pmids\": [\"35867755\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Derepression and nuclear repositioning of EBF1 from the heterochromatic nuclear envelope to the euchromatic nuclear interior in T-ALL cells instructs widespread genome refolding (alterations in compartments, domain boundaries, enhancer positioning) and promotes targeted therapy resistance.\",\n      \"method\": \"Hi-C, ATAC-seq, ChIP-seq, imaging of nuclear repositioning, integrated multi-omics in therapy-sensitive and -resistant T-ALL\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multi-omics integration with imaging, single lab, correlative repositioning mechanism\",\n      \"pmids\": [\"35182476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Acute in vivo protein degradation reveals that Ebf1 functions predominantly as a transcriptional activator by inducing open chromatin at its target genes; Ebf1 represses Wapl (cohesin-release factor) to mediate prolonged loop extrusion across the Igh locus; Ebf1 directly activates surrogate light-chain genes Igll1 and Vpreb1 in pro-B cells; Ebf1 has largely unique target genes compared to E2A and Pax5 and is essential for early B cell maintenance.\",\n      \"method\": \"Acute protein degradation in mice (degron system), ATAC-seq, ChIP-seq, RNA-seq across pro-B, small pre-B, and immature B cells\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vivo acute protein degradation with genome-wide chromatin and transcriptome analysis, rigorous controls\",\n      \"pmids\": [\"39179932\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"EBF1 is a pioneer transcription factor with a pseudoimmunoglobulin-like/Rel-homology-fold DNA-binding domain and a prion-like C-terminal domain that mediates phase separation with FUS, enabling Brg1-dependent chromatin remodeling; it acts downstream of E2A and IL-7R/STAT5 signaling to activate a hierarchical network of B-lineage genes (including Pax5, Foxo1, surrogate light chains, Myc, and Igh locus accessibility via Wapl repression), represses alternative lineage programs (Id2, Id3, C/EBPalpha, PU.1, TCF-1) in concert with the CCR4-NOT complex, and functions at multiple subsequent stages of B cell development to control proliferation (via Myc), survival (via c-Myb/Bcl-xL), signaling (BAFF-R/BCR-Akt), and class switch recombination, while also regulating adipogenesis, osteoblast/adipocyte balance, neuronal differentiation, and pericyte commitment in non-hematopoietic lineages.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"EBF1 is a lineage-instructive pioneer transcription factor that specifies and maintains the B lymphocyte program, acting at the earliest committed progenitor stages before immunoglobulin gene rearrangement [#0, #14]. It operates within a transcriptional hierarchy downstream of IL-7R/STAT5 signaling and the E2A protein E12, which induce EBF1 expression, and downstream of Runx1-Cbfβ, which epigenetically activates the Ebf1 promoter [#3, #10, #26]; EBF1 in turn sustains its own expression through an autoregulatory loop and wires a positive feedback circuit with FOXO1 [#7, #23]. EBF1 recognizes palindromic DNA sites through a pseudoimmunoglobulin-like/Rel-homology-related DNA-binding domain bearing a unique zinc-coordination motif, dimerizes via an atypical helix-loop-helix domain, and activates transcription through a serine/threonine-rich activation domain [#1, #18, #19]. Its pioneer activity resides in a C-terminal prion-like domain that drives liquid-liquid phase separation with FUS and recruits the SWI/SNF remodeler Brg1, enabling EBF1 to open and demethylate previously naive chromatin ahead of accessibility formation [#15, #31, #35, #37]. Through these mechanisms EBF1 directly activates the B-cell network—Pax5, Foxo1, the surrogate light-chain genes Igll1/Vpreb1, and Myc—and promotes Igh locus accessibility by repressing the cohesin-release factor Wapl, while repressing alternative-lineage determinants including Id2, Id3, and TCF-1, an activity it also coordinates with the CCR4-NOT complex through a direct CNOT3 interaction [#2, #4, #14, #25, #32, #39, #43]. Loss of EBF1 in committed pro-B cells permits their conversion to T and innate lymphoid cells, and EBF1 additionally controls pro-B proliferation, survival, and BCR/BAFF-R signaling at later developmental stages [#22, #25, #27]. Beyond the B lineage, EBF1 governs striatal neuronal differentiation, the osteoblast/adipocyte balance, adipogenesis and adipocyte insulin signaling, bone-marrow stromal support of hematopoietic stem cells, and pericyte commitment, demonstrating broadly redeployed differentiation-control function [#5, #12, #17, #28, #38].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established that EBF1 is genetically required for B cell development at a defined stage, fixing its place in the B-lineage hierarchy before immunoglobulin rearrangement.\",\n      \"evidence\": \"Targeted gene disruption in mice with flow cytometry and gene expression analysis\",\n      \"pmids\": [\"7542362\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define direct molecular targets\", \"Did not establish DNA-binding mechanism\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Defined the modular architecture of EBF1, showing how a novel zinc-coordination DNA-binding domain, an HLH-related dimerization domain, and an activation domain together enable sequence-specific transactivation.\",\n      \"evidence\": \"Mutational analysis with DNA-binding and transcriptional activation assays using heterologous domain fusions\",\n      \"pmids\": [\"7796816\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural model at this stage\", \"C-terminal pioneer/phase-separation function not yet recognized\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstrated that EBF1 directly activates endogenous B-lineage target genes (surrogate light chains) in synergy with E2A, moving beyond requirement to direct gene control.\",\n      \"evidence\": \"Stable cDNA transfection in Ba/F3 cells with binding-site identification\",\n      \"pmids\": [\"9252117\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Synergy mechanism with E47 not resolved\", \"Chromatin context not assessed\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Placed E2A upstream of EBF1, ordering the transcription factor cascade of B-lineage specification.\",\n      \"evidence\": \"Ectopic E12 and EBF expression in a macrophage-like line with gene expression analysis\",\n      \"pmids\": [\"9705952\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of E2A-driven Ebf1 induction not defined\", \"Did not address feedback architecture\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identified Pax5 as a direct EBF1 target and demonstrated genetic collaboration between EBF1 and E2A, linking the two factors quantitatively in pro-B differentiation.\",\n      \"evidence\": \"Compound heterozygous mouse genetics with promoter binding and expression analysis\",\n      \"pmids\": [\"10435576\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not separate EBF1-dependent from Pax5-dependent commitment functions\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Extended EBF1 function beyond hematopoiesis, showing it controls striatal neuronal differentiation, indicating a broadly redeployed differentiation-control role.\",\n      \"evidence\": \"Knockout mouse with in situ hybridization and histology\",\n      \"pmids\": [\"10556054\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct neuronal targets not identified\", \"Mechanistic overlap with B-lineage function unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showed EBF1 is instructive rather than permissive for B fate, since enforced expression restricts hematopoietic output almost exclusively to B cells.\",\n      \"evidence\": \"Retroviral transduction of progenitors with transplantation and flow cytometry\",\n      \"pmids\": [\"12970188\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the repressive targets enforcing fate restriction\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Positioned IL-7R/STAT5 signaling upstream of EBF1 and showed EBF1 can substitute for IL-7R, integrating cytokine signaling into the transcriptional hierarchy.\",\n      \"evidence\": \"IL-7 and IL-7Ralpha knockout mice with retroviral EBF rescue and STAT5 experiments\",\n      \"pmids\": [\"15837809\", \"12811842\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative contribution of STAT5 versus other inputs to Ebf1 induction unresolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Established EBF1 as a dual activator/repressor that commits cells to B lineage partly independently of Pax5 by antagonizing C/EBPalpha, PU.1, and Id2.\",\n      \"evidence\": \"Conditional deletion plus ectopic expression with in vivo lineage and expression profiling\",\n      \"pmids\": [\"18176567\", \"18714008\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of alternative-lineage gene repression not defined at chromatin level\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Revealed the chromatin-reprogramming mechanism: EBF1 increases accessibility and initiates DNA demethylation via SWI/SNF (Brg1/Brm), opposed by Mi-2/NuRD, priming targets for Pax5.\",\n      \"evidence\": \"Inducible EBF:ER/Pax5:ER systems with shRNA knockdown, accessibility and methylation assays\",\n      \"pmids\": [\"19549820\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the EBF1 domain responsible for pioneering\", \"Phase-separation basis not yet known\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrated that EBF1-mediated repression of Id2 and Id3 is essential for B specification, and identified non-hematopoietic roles in the osteoblast/adipocyte balance and adipogenesis.\",\n      \"evidence\": \"In vivo rescue with Id overexpression; knockout histomorphometry; promoter activation and knockdown in adipocyte models\",\n      \"pmids\": [\"19122139\", \"19130908\", \"17060461\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Shared versus lineage-specific cofactors across tissues not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Provided high-resolution structural basis for DNA recognition, showing a pseudoimmunoglobulin/Rel-homology-related fold with a unique zinc knuckle and an atypical HLH dimerization motif.\",\n      \"evidence\": \"X-ray crystallography of the EBF1 dimer-DNA complex and isolated domains\",\n      \"pmids\": [\"20876732\", \"20592035\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the C-terminal/prion-like region not determined\", \"Did not address phase separation\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Mapped EBF1 genome-wide in a regulatory network with E2A and Foxo1, linking factor occupancy to enhancer histone marks in pro-B cells.\",\n      \"evidence\": \"ChIP-seq with genome-wide regulatory element and histone modification analysis\",\n      \"pmids\": [\"20543837\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direction of causality among the three factors not fully resolved here\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined EBF1 as a positive feedback partner of FOXO1 and a controller of pro-B proliferation, survival, and mature B-cell signaling via direct targets including c-Myb and Bcl-xL.\",\n      \"evidence\": \"Conditional inactivation, reciprocal depletion, forced target expression, and genome-wide ChIP-seq/RNA analysis\",\n      \"pmids\": [\"22431510\", \"23213261\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the EBF1-FOXO1 loop is initiated remains unresolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showed EBF1 actively maintains commitment, since its loss in committed pro-B cells permits conversion to T and innate lymphoid cells, and identified Runx1-Cbfβ as an upstream epigenetic activator of Ebf1.\",\n      \"evidence\": \"Conditional deletion with lineage tracing and ChIP; conditional Runx1/Cbfβ deletion with reporter mutagenesis and retroviral rescue\",\n      \"pmids\": [\"23812095\", \"22665574\", \"22473956\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism keeping alternative-lineage genes silenced after commitment not fully defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identified the CCR4-NOT complex as a direct EBF1 partner (via CNOT3 at His240) coupling EBF1 to mRNA stability and autoregulation, and defined adipocyte-specific genome-wide EBF1 functions in insulin signaling.\",\n      \"evidence\": \"SILAC mass spectrometry, H240A mutagenesis, conditional Cnot3 knockout; adipocyte ChIP-seq with metabolic assays\",\n      \"pmids\": [\"27807034\", \"24174531\", \"23569325\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How EBF1 directs gene-specific mRNA stability via CCR4-NOT not mechanistically resolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Localized pioneer function to the EBF1 C-terminal domain, which is required for de novo accessibility and demethylation at sites with limited co-occupancy by other factors.\",\n      \"evidence\": \"Genome-wide DNaseI HS, methylation, and ChIP-seq comparing EBF1wt and EBF1ΔC in Ebf1-/- progenitors\",\n      \"pmids\": [\"26982363\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biophysical basis of CTD pioneering not yet known at this point\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrated by time-resolved analysis that EBF1 occupancy precedes accessibility formation, formally establishing pioneer kinetics and a requirement for continuous EBF1 to maintain accessible domains.\",\n      \"evidence\": \"Inducible EBF1 in Ebf1-/- pre-pro-B cells with time-resolved ATAC-seq and ChIP-seq\",\n      \"pmids\": [\"29440261\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the molecular machinery converting binding to accessibility\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Provided the biophysical mechanism of pioneering: the CTD prion-like domain drives phase separation enhanced by FUS and recruits Brg1 into condensates to stabilize chromatin occupancy.\",\n      \"evidence\": \"Phase separation assays, FUS/Brg1 Co-IP, live imaging, FRAP, and heterologous PLD rescue\",\n      \"pmids\": [\"33159853\", \"32066955\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of condensate formation at endogenous loci not fully quantified\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established Myc as a direct EBF1 target driving pro-B expansion through defined enhancers, and extended EBF1 roles to pericyte commitment.\",\n      \"evidence\": \"Chromosome conformation, ATAC/ChIP-seq, CRISPR-Cas9 enhancer mutagenesis, and rescue; pericyte siRNA knockdown\",\n      \"pmids\": [\"33619557\", \"34272603\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of individual Myc enhancers in vivo not fully dissected\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Acute degradation showed EBF1 acts predominantly as an activator inducing open chromatin, with largely unique targets, and revealed it promotes Igh locus loop extrusion by repressing Wapl.\",\n      \"evidence\": \"In vivo degron-based acute degradation with ATAC-seq, ChIP-seq, and RNA-seq across B-cell stages\",\n      \"pmids\": [\"39179932\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How EBF1 represses Wapl mechanistically not resolved\", \"Stage-specific cofactor switching not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How EBF1 condensate formation, cofactor selection (CCR4-NOT, Brg1, FUS), and activator-versus-repressor output are integrated to produce cell-type-specific programs across B cells, adipocytes, neurons, stroma, and tumors remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No unified model linking phase separation to gene-specific outcomes\", \"Cross-tissue cofactor determinants unknown\", \"Mechanism of context-dependent repression incompletely defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 2, 4, 13, 22, 39, 43]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 18, 19]},\n      {\"term_id\": \"GO:0003700\", \"supporting_discovery_ids\": [4, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [37, 42]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [31, 35, 37]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 4, 22, 39, 43]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [15, 31, 35, 37, 43]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 14, 22, 27]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [5, 12, 17, 40]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"E2A/E47\", \"FOXO1\", \"CNOT3\", \"FUS\", \"Brg1/SMARCA4\", \"ZNF521\", \"MEF2C\", \"STAT5\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":7,"faith_total":7,"faith_pct":100.0}}